Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
32.42
+0.60 (1.89%)
At close: Jan 17, 2025, 4:00 PM
30.10
-2.32 (-7.16%)
Pre-market: Jan 21, 2025, 4:07 AM EST
Agios Pharmaceuticals Employees
As of December 31, 2023, Agios Pharmaceuticals had 386 total employees, including 383 full-time and 3 part-time employees. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$85,158
Profits / Employee
$1,746,912
Market Cap
1.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AGIO News
- 12 days ago - Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer - Business Wire
- 17 days ago - Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - GlobeNewsWire
- 4 weeks ago - European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease - GlobeNewsWire
- 6 weeks ago - Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat - GlobeNewsWire
- 2 months ago - Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Agios Reports Business Highlights and Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 - GlobeNewsWire